© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Lincomycin’s story kicked off in the 1960s, born from soil bacteria in the search for new antibiotics beyond penicillin. Researchers turned over soil samples and found Streptomyces lincolnensis, which ended up being a workhorse for clinics and farms. Over time, chemists refined ways to pull lincomycin from fermentation broths and stabilized it with hydrochloride salt, giving rise to the monohydrate form. By the late 1960s, doctors and veterinarians, frustrated by resistant infections, picked up on lincomycin’s advantages against Gram-positive bacteria. This hit at a point where infections outpaced many older antibiotics, and the need for new therapeutic options became urgent. Industry players organized production, with regulatory bodies stepping in to set rules for safety, purity, and clinical testing.
Lincomycin hydrochloride (monohydrate) takes shape as a white or nearly white crystalline powder, often found in vials or blister packs for clinics and hospitals. Most folks working in pharmaceuticals recognize its earthy, slightly bitter profile. This antibiotic lands both in injectable forms and as powders for oral solution, depending on the country and clinical practice. Veterinarians often keep it close due to its success in livestock, while physicians use it more selectively in humans. Product packaging tends to showcase details about solubility, dose, and administration, with individual manufacturers printing batch and expiry information front and center thanks to tight regulations. The product’s presence stretches from hospital pharmacies to feedlots, covering a broad territory in infection management.
Lincomycin hydrochloride monohydrate features a distinct crystalline form, slightly hygroscopic, usually stable at room temperature if kept away from moisture and direct light. Its formula, C18H34N2O6S•HCl•H2O, translates into a molecular weight hovering around 461. This salt dissolves easily in water and only partially in alcohol, making it practical for injections and solutions but tough to use in fatty ointments. Heat and humidity degrade it, so warehouses apply strict temperature controls—no one wants to see potency drop because of poor storage. One can spot its melting point at about 150°C, and chemists rely on infrared and NMR spectroscopy for quality checks in laboratory settings.
Manufacturers stamp every lot of lincomycin hydrochloride monohydrate with batch numbers, expiration dates, and guaranteed potency—typically between 90 to 110% of label claim. Containers must use protective packaging with tamper-evident seals, and inserts walk users through dosing, diluting, and potential hazards. Pharmacists and feed specialists look for United States Pharmacopeia (USP) or European Pharmacopoeia (Ph. Eur.) compliance marks. These standards keep impurities in check and make sure every vial, package, or feed additive runs through microbial and chemical assays before hitting shelves. Safety notices lean heavily on allergy alerts and administration instructions, reminding users of possible cross-sensitivity with clindamycin and other lincosamides.
Factories grow Streptomyces lincolnensis in fermenters, feeding the bacteria a balanced diet of sugars, nitrogen, and minerals. Operators monitor temperature and pH day and night, keeping cultures healthy and productive. When broth reaches peak lincomycin concentration, technicians filter out solids, pull the antibiotic from the liquid, and use solvent extraction alongside acidification to yield crude lincomycin. After that, a crystallization process produces the hydrochloride monohydrate salt. Purification usually involves repeated recrystallization and chromatography for removing byproducts. This whole process requires strict cleanliness, with careful separation of fermentation byproducts, disposal of waste streams, and batch-tracking through every stage.
Lincomycin’s base structure contains an amino acid, a sugar ring, and a thioether bridge. Chemists once tweaked its structure to create clindamycin, which packs a punch against anaerobic bacteria and works where lincomycin sometimes can’t. These modifications come from targeted methylation and chlorine substitution, making the derivative more lipophilic. Outside the lab, lincomycin holds up reasonably well in solution, provided it is buffered correctly. Acidic conditions and strong oxidizers can break down the molecule, so pharmacists avoid mixing with incompatible drugs in shared IV lines. Years of chemical study led to more stable formulations, cutting down drug loss during handling and storage.
Folks in the pharmaceutical world know lincomycin hydrochloride monohydrate by more than one name: some labels read simply “lincomycin hydrochloride,” others prefer trade names like Lincocin or Mycinject. Synonyms sneak into paperwork—sometimes it appears as “7(S),8(D)-7-Chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-prolyl)amino,” though most users stick to the main name or common brand. The veterinary sector hands out feed additives under related trade brands, especially in regions tasked with fighting swine dysentery or mycoplasma infections.
Hospitals take extra care with lincomycin, since allergic reactions and gastrointestinal disturbances don’t flare up until after a dose rolls in. Pharmacists check for cross-reactions, especially in anyone with prior allergies to clindamycin. Industrial-scale plants run workers through respirator checks and routine skin-protection procedures; powder handling means risk of respiratory, skin, and eye irritation. Packaging rooms install air filtration, and operators handle spills with defined protocols to keep occupational exposure down. Feed manufacturers, working under veterinary rules, rotate stock and train personnel about contamination and clean-down routines—a spilled batch means major loss if not handled right.
Human medicine leans toward lincomycin when bacteria show resistance to penicillin or in patients who can’t take other drugs. Doctors particularly see results against Streptococcus, Staphylococcus, and anaerobes, with deep-tissue infections or bone involvement leading the way. The drug plays a quiet but steady role in perioperative prophylaxis for orthopedic surgery and dental infections. In veterinary circles, lincomycin steps up for swine, poultry, and cattle, given as both injection and feed additive. Large-scale hog farms in North America and parts of Asia tune protocols around lincomycin to cut losses from respiratory and gastrointestinal diseases, though new rules in Europe aim to dial back usage over resistance concerns.
Researchers keep combing through modifications to improve lincomycin’s performance—both in cutting off resistance and limiting side effects. labs push to find molecules that anchor in bacterial ribosomes longer but exit the human body smoother. Long-term studies collect real-world clinical data to weigh effectiveness in stubborn infections. Diagnostic labs search for better screening tools to catch resistance trends earlier, which helps guide smarter use and safeguard remaining antibiotics. Recent grant funding steers teams toward biodegradable containers and waste management, since runoff from farms could push resistant genes into wild bacteria.
No drug walks free of risks. Lincomycin’s profile includes gut imbalances, with overgrowth of C. difficile raising the alarm on severe diarrhea. Researchers also map out risk of hypersensitivity, tracking rash, fever, and rare liver reactions. Dosing in children, the elderly, and folks with kidney or liver impairment calls for slower, adjusted regimens. Small animal models and long-term surveillance continue to flag potential bone marrow effects and rare cross-reactions, prompting manufacturers to maintain updated patient alerts and toolbox talks for busy clinical teams. Veterinary studies check for safe withdrawal times in food animals, since residue in meat and milk shapes how authorities manage farm-to-table safety.
Antibiotic resistance doesn’t slow down, and lincomycin faces an uphill battle as bacteria get smarter. Pharmaceutical developers look for combinations and new delivery systems that shore up its strengths without fueling resistance. Industry players in animal health work with regulators to manage environmental runoff, eyeing water treatment, soil monitoring, and waste containment as part of farm hygiene. Digital tracing and blockchain-based batch controls inch closer to reality, improving recalls and real-time tracing of problem lots. Some hope rests on synthetic biology tweaking the fermentation pathway, reducing byproducts and raising yields. All signs point to careful, targeted use, more public education, and research that’s a step ahead of bacterial adaptation.
Lincomycin hydrochloride (monohydrate) shows up in many veterinarians’ cabinets for one reason—bacterial infections in livestock. Swine, poultry, and a handful of other farm animals often face threats from respiratory and gastrointestinal diseases. Farmers can’t hang back and wait for recovery. A herd outbreak or a case of avian necrotic enteritis means lost animals and lost income. This antibiotic, derived from the actinobacterium Streptomyces lincolnensis, steps in for fast action against the culprits behind those infections: Gram-positive bacteria such as Staphylococcus, Streptococcus, and Mycoplasma.
Lincomycin blocks protein synthesis in bacteria. Without that machinery humming, the pathogens can’t multiply or survive. I’ve worked on farms where respiratory outbreaks threatened entire groups of piglets. When oral medications didn’t cut it, or if injections weren’t practical, lincomycin delivered through water or feed helped bring sick pens back to health. The turnaround isn’t magic, but when scours clear or coughs settle down, nobody questions if swift action mattered. There’s nothing theoretical about saving a flock or a litter in the real world of animal rearing.
Antibiotics touch a nerve these days, and for good reason. Widespread resistance worries every doctor and parent, whether you raise animals or not. The food chain connects us all. Lincomycin’s use draws scrutiny from regulators and the public, not just veterinarians. Agencies like the FDA keep a close watch, tightening the guidelines around when and how this drug helps livestock. In the U.S., producers need a prescription under veterinary oversight to use it. That’s the right balance. Farmers gain tools to fight disease, but misuse doesn’t slip through unchecked.
People who eat meat, eggs, and dairy benefit when farms contain outbreaks early and safely. Lincomycin stands out because it targets animal-specific ailments and rarely enters routine treatment plans for humans. Still, resistance genes don’t stick to a script; they move across boundaries—soil, water, and sometimes into humans. This risk keeps the pressure on for careful management and well-documented use.
Responsible use doesn’t have to mean less food on the table. Over the years, farms have integrated better hygiene, disease-resistant breeds, vaccination programs, and nutrition adjustments to cut down on antibiotics. Where lincomycin remains necessary, regular review of dosing, duration, and withdrawal times for meat or eggs makes a difference. I’ve seen firsthand how record keeping and honest vet-producer conversations keep antibiotic use targeted and limited, without gambling with animal welfare.
Some producers experiment with probiotics and other alternatives, trying to tilt the gut or respiratory environment in favor of good bugs. Progress is real but slow. Only a few replacements handle the toughest infections sufficiently, especially in high-density animal environments. In my experience, no alternative fully matches the speed and reliability of well-timed antibiotics for acute outbreaks—at least not yet. Still, combining new ideas with careful lincomycin use stretches its usefulness further and protects both animal and public health.
Doctors often turn to lincomycin hydrochloride monohydrate when dealing with certain stubborn bacterial infections. It belongs to a class of antibiotics that tackles gram-positive bacteria, especially when other medicines haven’t worked well. Lincomycin’s ability to help patients with infections like serious staph and strep keeps it an important option in the medical toolkit, especially as resistance climbs and choices grow limited.
Dosage doesn’t follow a set-it-and-forget-it formula. Age, weight, kidney and liver function, and severity of infection push doctors to individualize doses. In adults, the usual dose often ranges from 600 mg to 1,000 mg per injection, given two or three times a day by deep intramuscular injection or slow intravenous infusion. For kids, doctors adjust the dose based on body weight—usually 10 mg per kilogram per day, divided every 12 or 24 hours.
Some infections demand more aggressive treatment, which means higher doses or more frequent administration. If somebody struggles with kidney or liver issues, doctors often use lab numbers like creatinine clearance to make sure the medicine doesn’t build up and cause harmful effects. Dr. Mary Chang, an infectious disease specialist, cautions against self-adjustment: “Lincomycin can become toxic if taken in the wrong amounts. Always trust a doctor’s math over an online guess.”
Mistakes with antibiotics can come back to bite. Too little medicine weakens the punch, letting bacteria linger and adapt. If someone underdoses, the infection hangs around or comes roaring back. I remember a patient with severe tonsillitis who split his doses to “make them last.” His infection worsened, and he landed in the hospital with a resistant strain. This isn’t just personal—it’s an issue for everyone, as resistance quickly spreads through communities.
Using too much matters just as much. Side effects of lincomycin, such as diarrhea, serious allergic reactions, or even a life-threatening gut infection called C. difficile colitis, become more common as doses rise. Family doctors do routine check-ups and blood work for a reason: They’re looking out for these complications before they snowball.
A well-informed patient can spot dosing errors before they turn into real harm. Making sure to ask questions in the doctor’s office or pharmacy and double-checking medication labels can stop confusion up front. Hospitals and clinics invest heavily in clear communication and electronic prescribing tools that flag unusual doses. These steps make a real difference in preventing mistakes.
Veterinarians work with lincomycin, too, mostly for livestock and poultry. They follow similar principles, tailoring the amount for each species and condition. Dosing in animals often follows strict guidelines to prevent residues in meat or dairy, protecting both animal health and humans who eat those products.
There’s a lot of outdated information floating around online about antibiotic dosing. Trusting sources like the FDA-approved package insert, reputable medical references, and one-on-one talks with licensed professionals brings science back into the picture. For anyone taking lincomycin or helping someone else use it, dosing isn’t a guessing game—precision matters just as much as the medicine itself.
Doctors prescribe antibiotics like lincomycin to fight serious infections, especially those linked to certain bacteria. As someone who's seen antibiotics do great things, I know they help when other options don’t work. But each pill brings its own risks, often tucked into the fine print on the box. Too often, people brush aside the side effects and focus only on the bacteria. Yet these side effects shape whether the cure feels worse than the original problem.
Many people taking lincomycin hydrochloride run into stomach troubles. Nausea, vomiting, and diarrhea show up a lot. Sometimes, the medicine wipes out the “good” bacteria. There’s nothing fun about being stuck in the bathroom or struggling to keep food down. These reactions tell you the body isn’t always happy with harsh medications. In some cases, diarrhea turns dangerous. Clostridium difficile, a tough gut bug, can take over after antibiotics like lincomycin kill off their competition. That infection brings cramps, fever, and even dehydration. Hospitals see this regularly and treat it with a lot of care because it can quickly spiral.
Allergic reactions scare me most. Sometimes rashes appear, but occasionally swelling and trouble breathing pop up. That’s your immune system raising the alarm. With drugs like lincomycin, severe reactions like anaphylaxis need immediate attention. People with a history of allergies should always tell their doctor before starting new medication. I always ask pharmacists about warning signs when starting something new, and it’s saved me more than once.
The drug can also hit the liver and kidneys hard. Elevated liver enzymes or changes in urine color signal things are off. Regular checkups and reporting new symptoms give doctors the best chance to catch these problems early. Anyone who’s ever watched an older relative deal with medication side effects knows how quickly organ health can change.
In rare cases, lincomycin affects the blood. Low white blood cell counts, unexplained bruising, or new infections should make people talk to their doctors fast. Ignoring these symptoms puts folks at risk for much bigger problems than the infection they started with.
Another worry that’s less obvious involves antibiotic resistance. Taking lincomycin too often, or for the wrong reasons, can make bacteria tougher over time. This means future infections might need even more aggressive—and riskier—treatments. According to the CDC, over two million people in the U.S. each year get infections that don’t respond to the usual antibiotics, with thousands dying as a result. I’ve watched families struggle with infections doctors couldn’t treat, and it’s never something anyone should shrug off.
Side effects remind us no medication works in a vacuum. Doctors and pharmacists do their best, but patients should stay alert for any changes after starting lincomycin. Reading about possible problems, asking questions, and sharing honest feedback at appointments makes a world of difference. Listening to your body and not being afraid to raise concerns saves lives. I always keep written notes about my reactions to new meds and encourage friends and family to do the same. Sometimes, just one phone call to a nurse or doctor changes everything for the better.
Plenty of folks figure that antibiotics work like a fire hose—blast the problem and move on. Lincomycin Hydrochloride (Monohydrate) doesn’t quite fit that bill. This stuff shows up in hospitals and clinics when more common antibiotics trip up. It works by attacking bacteria hiding out in the body, but adding it to someone’s medicine mix opens the door to real medical headaches. Ignoring the drug interaction piece or the contraindications isn’t just a technical error; it can land people in the ER.
If someone comes in with a history of hypersensitivity to lincomycin or clindamycin, it’s a no-go for this drug. Allergy symptoms with these meds can spin out quickly, leading into dangerous territory like anaphylaxis. Folks who have faced colitis after antibiotic use also fall into a higher risk group. Giving lincomycin to anyone with a track record of antibiotic-associated colitis puts their life at risk for toxic megacolon or even death. Someone’s history matters here—ignoring old reactions for convenience can spark tragedy.
Lincomycin Hydrochloride doesn’t play nice with everything in the medicine cabinet. Mix it with muscle relaxants like vecuronium or similar agents used in surgery, and it may turn routine anesthesia into a crisis. Lincomycin blocks some nerve transmissions, making muscle weakness much worse than expected.
Some antibiotics work against each other. Lincomycin and erythromycin compete for the same bacterial targets, which turns both into blunt instruments when used together. Their effectiveness drops, setting the stage for treatment failure. This competition isn’t always obvious, especially in busy clinics or when people take multiple medicines for infections.
Another issue arises when adding lincomycin to drugs that affect the gut or immune system. There’s a risk of wiping out the good and bad bacteria, making a home for new infections like C. difficile. This bacteria brings symptoms like violent diarrhea and abdominal pain, and those cases can be tough to treat. Doctors who pay close attention to history and medication lists save lives by catching these warning signs before they explode into problems.
Doctors and pharmacists look past the labels and paperwork. The best ones ask real questions, listen, and notice details that computerized systems might miss. Patients often forget to mention over-the-counter medicines, supplements, or previous antibiotic rashes. Family stories about weird reactions to antibiotics or “bad stomach problems” matter here. Drawing out that information makes all the difference.
Medical teams track labs for liver and kidney health because lincomycin filters out through these organs. Want to avoid more problems? Watch those markers, especially in older patients or people with chronic illnesses. Slowed metabolism or struggling kidneys turn a safe dose into a dangerous one. Communicating this clearly with everyone involved, from patients to nurses, heads off disaster.
There’s no magic fix for drug interactions, but building strong systems helps. Doctors should double-check drug lists, ask about allergy history, and document reactions. Electronic records help sometimes but never replace direct conversations. Teaching patients and families how to spot early signs of allergic reactions or severe diarrhea means they’ll call for help before it’s too late. Pharmacies flag drug interactions, and clinical teams follow up rather than brushing off those alerts. In my own work, a ten-second chat with a nurse or pharmacist about a possible drug clash has dodged plenty of close calls. No algorithm beats human attention, and experience on both sides of the counter saves lives.
Pharmacies, clinics, and labs work with many antibiotics, and lincomycin hydrochloride (monohydrate) stands among the trusted tools for fighting tough bacterial infections. Once that shipment gets dropped off—fresh from the supplier—how teams store every vial or bulk pouch can shape patient care. It’s one of those behind-the-scenes decisions that matters to real people, far from the pages of material safety data sheets. Leaving this active compound in the wrong place or at the wrong temperature does more than risk dollars; it can dull potency or invite dangerous contamination.
Manufacturers know the risks. Most recommend a cool, dry spot as the best option for storing lincomycin hydrochloride. In practice, this looks like room temperature—usually between 15°C and 30°C—far from any sources of moisture or heat. Cold, drafty storage areas sometimes create condensation; so do sharp temperature swings, both of which can force clumping or encourage breakdown. As someone who once worked in a hospital storeroom, I remember how easy it was for busy staff to overlook such details. Yet every temperature spike or minor water leak can start a slow falloff in the antibiotic’s strength. Digital temperature loggers help by sounding alarms once things get out of the safe range, giving staff a clear reminder before costly losses hit the shelf.
Humidity often becomes the silent thief in storerooms. Paper labels peel, powder turns sticky, and—worst of all—water can help bacteria or fungi get a tiny foothold. Even a loose cap or tiny crack lets in trouble over weeks or months. Every supplier packs lincomycin hydrochloride in moisture-resistant containers for good reason; those vials, drums, or bottles lock out water and block contamination. Teams who add an extra desiccant pouch or keep everything off the concrete floor gain another layer of protection. In my experience, no one plans for pipes to burst or for AC to fail, but the teams who store their medicines on raised racks or dry shelves sleep better at night.
Bright room lights, or worse—direct sunlight—can spark chemical changes over time. If anyone has stacked clear jars near a window, sunbeams show off the dust and also kick off slow, unwanted reactions in sensitive powders. Pharmacists prefer dark, labeled bins or cabinets, sometimes marked off specifically for antibiotics and kept away from the main traffic of the storeroom. Labeled bins make audits easy and alert anyone in the room to check the expiration or lot numbers fast, which keeps mistakes out of the chain before compounding or dispensing.
Following best practices for storage isn’t just about ticking a compliance box. Every staff member from janitor to pharmacist plays a role—spotting leaks, logging temperatures, flagging expired lots. Drug shortages happen; mistakes spiral into recalls. I’ve seen how one corner-cutting move leads down the wrong path. Real accountability comes from keeping training fresh and involving everyone in safety checks. Refresher sessions aren’t a waste; they prevent bigger losses. Storage is a living safety net built by real people who care about the next patient in line.
Modern systems—from remote sensors to airtight smart containers—bring down the risk of human error. Still, a great storage policy relies on constant attention, trust in your team, and respect for the value of every shipment behind that storeroom door. Watching over lincomycin hydrochloride supplies could mean the difference between an effective treatment and a near-miss. The science makes rules, but people keep the promise.
| Names | |
| Preferred IUPAC name | (2S,4R)-N-[(1S,2R)-1-Methyl-4-propylpyrrolidin-2-yl]-1-thio-D-glucopyranose hydrochloride monohydrate |
| Other names |
Lincomycin HCl Monohydrate Lincomycin hydrochloride monohydrate Lincomycin hydrochloride Lincomycin HCl LINCOMYCIN HYDROCHLORIDE, MONOHYDRATE |
| Pronunciation | /ˌlɪŋ.kəˈmaɪ.sɪn haɪˈdrɒk.lə.raɪd ˌmɒn.əˈhaɪ.dreɪt/ |
| Identifiers | |
| CAS Number | '859-18-7' |
| 3D model (JSmol) | `3D model (JSmol)` string for **Lincomycin Hydrochloride (Monohydrate)**: ``` CC1CC(NC(=O)C2=CC=CC=C2Cl)C(C(C1O)O)OC(C)C(=O)NC(C)C.Cl.O ``` This is a **SMILES string** which can be used as input in JSmol or other molecular viewers. |
| Beilstein Reference | 1498329 |
| ChEBI | CHEBI:75254 |
| ChEMBL | CHEMBL1201191 |
| ChemSpider | 10482054 |
| DrugBank | DB01627 |
| ECHA InfoCard | 03ff7094-447a-42b1-999e-2da083b4b4a9 |
| EC Number | 253-381-2 |
| Gmelin Reference | 104497 |
| KEGG | D08125 |
| MeSH | D008073 |
| PubChem CID | 71587578 |
| RTECS number | OJ0175000 |
| UNII | 8V7Q8Q21DR |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C18H34ClN2O6S·H2O |
| Molar mass | 461.96 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.23 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -1.6 |
| Acidity (pKa) | pKa = 7.6 (Predicted) |
| Basicity (pKb) | 7.6 |
| Magnetic susceptibility (χ) | -68.0e-6 cm³/mol |
| Viscosity | Viscous liquid |
| Dipole moment | 5.72 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Lincomycin Hydrochloride (Monohydrate) is 680 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01FF02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause an allergic skin reaction. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Wash face, hands and any exposed skin thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection. |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Flash point | > 201.2 °C |
| Explosive limits | Non-explosive |
| Lethal dose or concentration | LD₅₀ (oral, rat): 1300 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 1300 mg/kg |
| NIOSH | QL0525000 |
| PEL (Permissible) | 5 mg/m3 |
| REL (Recommended) | 1 mg/kg body weight |
| Related compounds | |
| Related compounds |
Lincomycin Clindamycin Clindamycin Phosphate Clindamycin Hydrochloride Clindamycin Palmitate Pirlimycin Pivampicillin-Lincomycin |
